Iotrolan
 | |
| Systematic (IUPAC) name | |
|---|---|
|
2,4,6-triiodo-5-{N-methyl-2-[methyl({2,4,6-triiodo-3,5-bis[(1,3,4-trihydroxybutan-2-yl)carbamoyl]phenyl})carbamoyl]acetamido}-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy category |
|
| Legal status |
|
| Identifiers | |
| CAS Number |
79770-24-4  |
| ATC code | V08AB06 |
| PubChem | CID 3738 |
| UNII |
16FL47B687  |
| KEGG |
D01714 |
| ChEMBL |
CHEMBL1200555 |
| Chemical data | |
| Formula | C37H48I6N6O18 |
| Molar mass | 1626.23 g/mol |
| (what is this?) (verify) | |
Iotrolan (trade name Isovist) is a radiocontrast agent, a substance used to improve the visibility of body structures on images obtained by X-ray techniques. It is particularly used to image spaces surrounding the central nervous system, such as the ventricles, after injection into the cerebrospinal fluid.[1] It can also be used to image joint spaces and in endoscopic retrograde cholangiopancreatography (ERCP).
Chemically, the substance is a dimer of triiodinated isophthalic acid derivatives.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Tuesday, May 05, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.